Home Featured Page 251

Featured

Latest

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Entheon Biomedical Corp. Provides Corporate Update

MindMed Announces 2021 Q1 Financial Results; Cash Balance of $160m USD...

Psychedelic Bulletin: MAPS Study Published in Nature Medicine; Numinus’ Hiring Spree;...

PTSF59 – Bipolar and Psychedelics, with Benjamin Mudge

MindMed Announces Appointment of Dr. Sarah Y. Vinson as Additional Director

Routes of Administration in Psychedelic Drug Research

COMPASS Pathways plc announces financial results and business highlights for the...

PharmaDrug Enters into Employment Agreement with Dr. Paul Van Slyke and...

The World Boxing Council and Wesana Health Announce Multi-Year Joint Efforts...

Silo Pharma announces important milestone. Investigator led study using Psilocybin to...

1...250251252...299 Page 251 of 299

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Entheon Biomedical Corp. Provides Corporate Update

MindMed Announces 2021 Q1 Financial Results; Cash Balance of $160m USD...

Psychedelic Bulletin: MAPS Study Published in Nature Medicine; Numinus’ Hiring Spree;...

PTSF59 – Bipolar and Psychedelics, with Benjamin Mudge

MindMed Announces Appointment of Dr. Sarah Y. Vinson as Additional Director

Routes of Administration in Psychedelic Drug Research

COMPASS Pathways plc announces financial results and business highlights for the...

PharmaDrug Enters into Employment Agreement with Dr. Paul Van Slyke and...

The World Boxing Council and Wesana Health Announce Multi-Year Joint Efforts...

Silo Pharma announces important milestone. Investigator led study using Psilocybin to...

EDITOR PICKS

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY